{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T02:27:31Z","timestamp":1696904851555},"reference-count":41,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.vaccine.2007.05.043","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T11:11:25Z","timestamp":1181646685000},"page":"5978-5984","source":"Crossref","is-referenced-by-count":4,"title":["Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed anthrax vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"Diane R.","family":"Bienek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheow K.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.05.043_bib1","unstructured":"Anthrax Vaccine Adsorbed. Package insert. Lansing, MI: BioPort Corporation; 1999."},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.043_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/CDLI.11.5.919-923.2004","article-title":"Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum","volume":"11","author":"Semenova","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.05.043_bib3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","article-title":"Specific, sensitive, and quantitative enyzme-linked immunosorbent assay for human immunoglobulin g antibodies to anthrax toxin protective antigen","volume":"8","author":"Quinn","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.043_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/CDLI.11.1.50-55.2004","article-title":"Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins","volume":"11","author":"Biagini","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.043_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/CVI.13.5.541-546.2006","article-title":"Rapid, sensitive, and specific lateral flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood","volume":"13","author":"Biagini","year":"2006","journal-title":"Clin Vacc Immunol"},{"key":"10.1016\/j.vaccine.2007.05.043_bib6","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.05.043_bib7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1525-0016(03)00180-1","article-title":"Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland","volume":"8","author":"Tucker","year":"2003","journal-title":"Mol Ther"},{"issue":"7","key":"10.1016\/j.vaccine.2007.05.043_bib8","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1128\/IAI.73.7.4043-4053.2005","article-title":"Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen","volume":"73","author":"Aloni-Grinstein","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.05.043_bib9","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.176.3.1776","article-title":"Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens","volume":"176","author":"Duverger","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.05.043_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1211\/jpp.58.4.0003","article-title":"Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice","volume":"58","author":"Sloat","year":"2006","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.05.043_bib11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11095-006-0206-9","article-title":"Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic\u2013polyribocytidylic acid induced strong mucosal and systemic immunities","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.043_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11095-005-9078-7","article-title":"Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine-DNA particles","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2007.05.043_bib13","series-title":"Program ELISA for Windows","author":"Plikaytis","year":"1996"},{"issue":"3","key":"10.1016\/j.vaccine.2007.05.043_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.277.3.254","article-title":"Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing","volume":"277","author":"Gallo","year":"1997","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.043_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1098-2825(1997)11:1<63::AID-JCLA10>3.0.CO;2-N","article-title":"Evaluation of two novel immunoassays designed to detect HIV antibodies in oral fluids","volume":"11","author":"Saville","year":"1997","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"10.1016\/j.vaccine.2007.05.043_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CDLI.6.4.577-580.1999","article-title":"A simple saliva-based test for detecting antibodies to human immunodeficiency virus","volume":"6","author":"Schramm","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.05.043_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jcp.53.4.314","article-title":"Western blotting is useful in the salivary diagnosis of Helicobacter pylori infection","volume":"53","author":"Ballam","year":"2000","journal-title":"J Clin Pathol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.05.043_bib18","first-page":"2025","article-title":"The use of oral fluid for hepatitis C antibody screening","volume":"89","author":"Sherman","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.043_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jmv.10463","article-title":"Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots","volume":"71","author":"Judd","year":"2003","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.05.043_bib20","first-page":"1460","article-title":"Non-invasive immunodiagnosis of Schistosomiasis japonica: the detection of specific antibodies in saliva","volume":"115","author":"Wang","year":"2002","journal-title":"Chin Med J"},{"key":"10.1016\/j.vaccine.2007.05.043_bib21","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1016\/j.vaccine.2006.01.054","article-title":"Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series","volume":"24","author":"Pittman","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2007.05.043_bib22","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.vaccine.2006.11.005","article-title":"The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine","volume":"25","author":"Lininger","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.043_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/IAI.52.2.356-363.1986","article-title":"Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"52","author":"Turnbull","year":"1986","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.043_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/IAI.52.2.509-512.1986","article-title":"Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig","volume":"52","author":"Little","year":"1986","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.043_bib25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/IAI.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2007.05.043_bib26","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0264-410X(94)90027-2","article-title":"Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs","volume":"12","author":"Ivins","year":"1994","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2007.05.043_bib27","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/0264-410X(95)00139-R","article-title":"Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs","volume":"13","author":"Ivins","year":"1995","journal-title":"Vaccine"},{"issue":"23\/24","key":"10.1016\/j.vaccine.2007.05.043_bib28","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"issue":"11\/12","key":"10.1016\/j.vaccine.2007.05.043_bib29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.043_bib30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","article-title":"In vitro correlate of immunity in an animal model of inhalational anthrax","volume":"87","author":"Pitt","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"32","key":"10.1016\/j.vaccine.2007.05.043_bib31","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.05.043_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.05.043_bib33","series-title":"The anthrax vaccine: Is it safe? Does it work?","year":"2002"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.043_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1034\/j.1600-0765.2001.00360.x","article-title":"Parotid salivary S-IgA antibodies during experimental gingivitis in smokers and non-smokers","volume":"37","author":"Lie","year":"2002","journal-title":"J Periodontal Res"},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.043_bib35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0030-4220(82)90457-1","article-title":"Salivary immunoglobulin A levels in normal subjects, tobacco smokers, and patients with minor aphthous ulceration","volume":"53","author":"Bennet","year":"1982","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.043_bib36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1399-3038.2006.00490.x","article-title":"The effects of maternal smoking on early mucosal immunity and sensitization at 12 months of age","volume":"18","author":"Noakes","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.05.043_bib37","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/milmed\/168.12.1034","article-title":"Immune and hormonal changes following intense military training","volume":"168","author":"Gomez-Merino","year":"2003","journal-title":"Mil Med"},{"issue":"3","key":"10.1016\/j.vaccine.2007.05.043_bib38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00421-005-1317-4","article-title":"Living high-training low altitude training: effects on mucosal immunity","volume":"94","author":"Tiollier","year":"2005","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.vaccine.2007.05.043_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1569-2574(08)60056-8","article-title":"Local immunocompetence and salivary cortisol in confinement","volume":"5","author":"Hennig","year":"1996","journal-title":"Adv Space Biol Med"},{"issue":"6","key":"10.1016\/j.vaccine.2007.05.043_bib40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1399-302X.1994.tb00284.x","article-title":"Degradation of immunoglobulin G by periodontal bacteria","volume":"9","author":"Jansen","year":"1994","journal-title":"Oral Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.05.043_bib41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/07420529909116864","article-title":"Bright light exposure during the daytime affects circadian rhythms of urinary melatonin and salivary immunoglobulin A","volume":"16","author":"Park","year":"1999","journal-title":"Chronobiol Int"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T02:19:05Z","timestamp":1587608345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07006172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":41,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0264410X07006172"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.05.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}